(Q43054632)
Statements
Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinoma (English)
C Ferté
B Besse
E Dansin
F Parent
M-P Buisine
M-C Copin
scientific article published in June 2010
No description defined